Related Experiment Video
Updated: Feb 27, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Indole-3-Acetic Acid as a Putative Selective AhR Modulator Counteracts Skatole-Induced Dual-Hit Toxicity in
Chihiro Takei1, Hidehisa Shimizu1,2,3,4,5
1Graduate School of Natural Science and Technology, Shimane University, 1060 Nishikawatsu-Cho, Matsue 690-8504, Shimane, Japan.
High skatole levels promote colorectal cancer (CRC) cell growth via dual pathways. Indole-3-acetic acid (IAA) counteracts this by acting as a selective AhR modulator, suggesting gut microbiome balance is key for CRC prevention.
Area of Science:
- Microbiology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer (CRC) incidence is rising, linked to diet-induced gut dysbiosis.
- This dysbiosis involves decreased protective indole-3-acetic acid (IAA) and increased toxic skatole (3-methylindole).
- Mechanisms of skatole-induced malignancy and IAA's counteraction are unclear.
Purpose of the Study:
- To investigate the molecular mechanisms of skatole-induced CRC cell proliferation.
- To determine if IAA can counteract skatole's toxic effects.
- To explore IAA's potential role as a selective AhR modulator (SAhRM).
Main Methods:
- Treatment of HCT-116 CRC cells with skatole and IAA.
- Analysis of aryl hydrocarbon receptor (AhR) activity and ERK MAPK pathway activation.
- Assessment of cell proliferation and cell cycle progression.
Main Results:
- Skatole (500 µM) significantly promoted CRC cell proliferation via AhR-dependent and ERK MAPK-dependent pathways.
- IAA (250 µM) abrogated skatole-induced proliferation, restoring cell growth.
- IAA acted as a functional antagonist, reprogramming AhR signaling to uncouple MAPK phosphorylation from cell cycle progression.
Conclusions:
- IAA may function as a SAhRM, mitigating skatole's pro-proliferative effects.
- Restoring the gut IAA/skatole balance, possibly via targeting indoleacetate decarboxylase (IAD) or resistant starch, is a potential CRC prevention strategy.
More Related Videos
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

